$RWAY

Runway Growth Finance Corp. (RWAY): Entry into a Material Definitive Agreement

Runway Growth Finance Corp. (RWAY) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 rway-ex10_1.htm EX-10.1 EX-10.1 Execution Version Eighth Amendment to Amended and Restated Credit Agreement and Waiver This Eighth Amendment to Amended and Restated Credit Agreement and Waiver , dated as of July 13, 2026 (the “Amendment” ), is made pursuant to that cert

Original reporting
Published Jul 15, 2026, 8:49 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 15, 2026, 8:50 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$RWAY
Neutral
medium confidence
Mentioned
$RWAY
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$RWAYNeutralMed
01

Why it matters

RWAY obtained a waiver from its administrative agent and lenders for two subject defaults: (1) noncompliance with an SWK account closure requirement and (2) acquiring MOD3 Pharma Inc. in contravention of subsidiary/guaranty requirements, with MOD3 Pharma later merged into the borrower.

02

Market read

This is a credit agreement and waiver disclosure that can affect perceived default risk and covenant compliance optics, even without detailed pricing terms in the excerpt.

03

What to watch

The excerpt does not show the amended financial terms or any changes to covenants, so traders should verify Exhibit A for rate, maturity, collateral, and covenant revisions before repricing credit risk.

Relevance 6/10Novelty 6/10Timing: Filed July 15, 2026, covering a credit agreement amendment effective June 30, 2026.

Background

The 8-K reports Item 1.01 and Item 2.03, including an Eighth Amendment to an Amended and Restated Credit Agreement and a waiver of specified “Subject Defaults.”

Company-level read

Ticker impact

$RWAYNeutralMedium confidence
Context

Runway Growth Finance Corp. entered an Eighth Amendment to its credit agreement, waiving specified defaults tied to the SWK account closure and MOD3 Pharma acquisition.

Expected impact

Near-term downside risk from a potential default appears reduced, but the market may treat it as a credit-quality/covenant signal rather than a growth catalyst.

Evidence & confidence

The 8-K discloses a material definitive agreement and a one-time waiver of “Subject Defaults,” but it does not provide economic terms (rates, maturity, leverage) in the excerpt, limiting precision on magnitude of impact.

Market effects

Credit agreement amendments and waivers can be read across to other specialty finance issuers’ covenant sensitivity, but this is company-specific in the excerpt.

No clear regional transmission beyond US credit markets.

Limited global relevance; lenders and agents are US-focused in the excerpt.

Counterpoint

The waiver is explicitly limited and one-time, so it may not prevent future covenant pressure if similar compliance issues recur.

Key entities

  • Runway Growth Finance Corp.

    Borrower under the amended credit agreement; requested and received a limited waiver of specified defaults.

  • KeyBank National Association

    Administrative agent for the lenders under the credit agreement amendment.

  • MOD3 Pharma Inc.

    Acquired in contravention of subsidiary/guaranty requirements; later merged into the borrower.

  • SWK Funding LLC

    Referenced in the consent and waiver tied to the Wells account closure requirement.

Related articles

$RWAYMedAI 8/10

Runway Growth Q2 2026 slides: SWK deal drives 71% NII jump

Runway Growth Finance Corp. (RWAY) released Q2 2026 investor slides on Aug. 7, citing the April 6 SWK Holdings acquisition as a driver of results. Net investment income rose 71.7% to $18.2M ($0.43/share). Total investment income rose to $37.0M. NAV per share fell to $11.91 after $8.1M transaction expenses. Shares rose 13.21% to $6.77.

$RWAYMed

Runway Growth Finance Corp. (RWAY): Results of Operations and Financial Condition

Runway Growth Finance Corp. (RWAY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 rway-ex99_1.htm EX-99.1 EX-99.1 Runway Growth Finance Corp. Reports Second Quarter 2026 Financial Results Delivered Total and Net Investment Income of $37.0 million and $18.2 million, Respectively Investment Portfolio of $1.2 billion Conference Call on Friday, August 7,

$RWAYMed

Runway Growth Finance Corp. Provides Second Quarter 2026 Business and Portfolio Update

Runway Growth Finance Corp. (Nasdaq: RWAY) reported a Q2 2026 business and portfolio update for the quarter ended June 30, 2026. The company said adviser and affiliates plan to buy up to 10% of outstanding shares if trading remains below 70% of NAV, and it has a $15.0 million repurchase authorization. Q2 funded $85.8 million in new and existing investments and reported $36.5 million in liquidity events.

$RWAYMed

Bulldog Investors Calls on Runway Growth Finance Corp. (RWAY) to Expand Its Share Repurchase Program

Bulldog Investors, a >3% shareholder of Runway Growth Finance Corp. (RWAY), urged management to materially expand RWAY’s share repurchase program. It cites RWAY’s May 7 $15m buyback at $6.83 and subsequent decline to $5.49 by July 2, with shares trading ~55% below last reported NAV ($12.13). Bulldog also asks for reduced debt and warns it may nominate directors.

$RWAYMed

Is Runway Growth Finance (RWAY) One of the Top 10 Dividend Stocks with 10%+ Yield?

BofA downgraded Runway Growth Finance (RWAY) to Underperform from Neutral and cut its price target to $5.50 from $9, citing ongoing earnings pressure, higher non-accruals, and declining NAV per share, with expectations of further dividend reset. RWAY reported Q1 2026 total investment income of $29.5M and net investment income of $10.6M; two loans moved to nonaccrual.

$SKHYMed

SK Hynix’s $38 billion buildout has a name attached: Nvidia

SK Hynix (SKHY) approved about 54.3 trillion won (about $38.3B) for two memory plants through 2031, Reuters reported. About 35.2 trillion won funds a DRAM fab in Yongin (Y2) with construction starting July 2027 and first cleanroom June 2029. Remaining 19.1 trillion won supports a NAND plant in Cheongju. Reuters also said it is reviewing further shareholder returns.